Sequenom Signs Supply Deal for T21 Test with Illumina; Firms to Collaborate on Regulatory Approval

Under the three-year supply agreement for Illumina's HiSeq 2000 platform, Sequenom and its subsidiaries will purchase sequencing equipment and consumables for use in the development of its Down syndrome test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.